Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart.

Ihlo CA, Lauritzen T, Sturis J, Skyggebjerg O, Christiansen JS, Laursen T.

Diabet Med. 2011 Feb;28(2):230-6. doi: 10.1111/j.1464-5491.2010.03149.x.

PMID:
21219436
2.

Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Lindholm A, Jacobsen LV.

Clin Pharmacokinet. 2001;40(9):641-59. Review.

PMID:
11605714
3.

[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H.

Diabetes Metab. 2000 Dec;26(6):513-9. Review. French. Erratum in: Diabetes Metab 2001 Feb;27(1):86.

PMID:
11173725
4.
5.

[Insulin aspart].

Namba M.

Nihon Rinsho. 2002 Sep;60 Suppl 9:492-7. Review. Japanese. No abstract available.

PMID:
12387040
6.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
7.

Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.

Kinsley B.

Clin Ther. 2007;29 Suppl D:S153-60. doi: 10.1016/j.clinthera.2007.12.015. Review.

PMID:
18191067
8.

Insulin aspart: a review.

Owens D, Vora J.

Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):793-804. Review.

PMID:
17014395
9.

Insulin during pregnancy, labour and delivery.

de Valk HW, Visser GH.

Best Pract Res Clin Obstet Gynaecol. 2011 Feb;25(1):65-76. doi: 10.1016/j.bpobgyn.2010.10.002. Epub 2010 Dec 24. Review.

PMID:
21186142
10.

Deus ex machina: the use of technology in type 1 diabetes.

Kerr D, Partridge H.

Prim Care Diabetes. 2011 Oct;5(3):159-65. doi: 10.1016/j.pcd.2010.11.001. Epub 2011 Jul 2. Review.

PMID:
21727052
11.

Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review.

Anstey J, Yassaee A, Solomon A.

Diabet Med. 2015 Oct;32(10):1279-88. doi: 10.1111/dme.12740. Epub 2015 Mar 31. Review.

PMID:
25763540
12.

Approach to the adult hospitalized patient on an insulin pump.

Lansang MC, Modic MB, Sauvey R, Lock P, Ross D, Combs P, Kennedy L.

J Hosp Med. 2013 Dec;8(12):721-7. doi: 10.1002/jhm.2109. Epub 2013 Nov 13. Review.

PMID:
24227761
13.

Can glucose be monitored accurately at the site of subcutaneous insulin delivery?

Ward WK, Castle JR, Jacobs PG, Cargill RS.

J Diabetes Sci Technol. 2014 May;8(3):568-74. doi: 10.1177/1932296814522805. Epub 2014 Feb 18. Review.

14.

[Type 1 diabetes mellitus].

Sasaki T, Tajima N.

Nihon Rinsho. 2006 Sep 28;Suppl 3:26-30. Review. Japanese. No abstract available.

PMID:
17022494
15.

Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Kraegen EW, Chisholm DJ.

Clin Pharmacokinet. 1985 Jul-Aug;10(4):303-14. Review.

PMID:
3899451
16.

Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms.

Rasmussen CH, Røge RM, Ma Z, Thomsen M, Thorisdottir RL, Chen JW, Mosekilde E, Colding-Jørgensen M.

Eur J Pharm Sci. 2014 Oct 1;62:65-75. doi: 10.1016/j.ejps.2014.05.010. Epub 2014 May 27. Review.

PMID:
24878388
17.

Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins.

Kagan L.

Drug Metab Dispos. 2014 Nov;42(11):1890-905. doi: 10.1124/dmd.114.059121. Epub 2014 Aug 13. Review.

Supplemental Content

Support Center